BioSpace News Archive

Enanta Pharmaceuticals, Inc. announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strategy Officer, will participate in a fireside chat at the JMP Securities Life Sciences Conference on May 14, 2024 at 10:00 a.m. ET in New York, NY.

Scholar Rock, a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, reported financial results and corporate updates for the first quarter ended March 31, 2024.

Bristol Myers Squibb announced that the company will participate in two upcoming investor conferences in May 2024.

Adicet Bio, Inc. announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the 2024 Citizens JMP Life Sciences Conference being held from May 13-14, 2024 in New York.

TriSalus Life Sciences® Inc., an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced the appointment of Liselotte Hyveled to its Board of Directors.

Syros Pharmaceuticals announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, May 14, 2024 to report its first quarter 2024 financial results and provide a corporate update.

Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system disorders, highlights oral and poster presentations on the Company’s preclinical gene therapy programs and vector engineering platform at the 27th ASGCT Annual Meeting being held May 7 – 11, 2024 in Baltimore, MD.

Sapio Sciences, the science-awareTM lab informatics platform, announced Sapio ELNSM release 24.5.

Seaport Therapeutics, a clinical-stage biopharmaceutical company that is charting a proven path in neuropsychiatry, announced the appointment of Denice Torres, J.D., to its Board of Directors.

Diality Inc., a medical device company developing the Moda-flxTM Hemodialysis System, announced that Ravi Parthasarathy has joined the company as Chief Technology Officer.